{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["biotechnology", "countries", "inventors", "patent classifications", "patent landscape", "patent quality parameters", "pharmaceuticals"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31612798", "DateCompleted": {"Year": "2020", "Month": "02", "Day": "17"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "17"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.4155/ppa-2019-0017"], "Journal": {"ISSN": "2046-8962", "JournalIssue": {"Volume": "8", "Issue": "5", "PubDate": {"Year": "2019", "Month": "Sep"}}, "Title": "Pharmaceutical patent analyst", "ISOAbbreviation": "Pharm Pat Anal"}, "ArticleTitle": "International collaboration generates high quality clusters of pharmaceutical patents.", "Pagination": {"StartPage": "193", "EndPage": "202", "MedlinePgn": "193-202"}, "Abstract": {"AbstractText": ["The worldwide active patent portfolio has nearly doubled in numbers and strength since 2000. The number of active pharmaceutical patent families has tripled in the same time period. The quantitative growth results mostly from a surge of patents from China, half of them classified in A61K36 ('medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants'). High-quality patents exhibit a slower growth curve, and cluster within the three areas biologicals; heterocyclic compounds, and cancer drugs. However, the highest concentration of high-quality patents was found when selecting patents listing inventors from at least two out of the five most important countries of origin for pharmaceutical patents: China, EP countries, Japan, South Korea and the USA."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Swiss Federal Institute of Intellectual Property, Stauffacherstrasse 65, CH-3003 Bern, Switzerland."}], "LastName": "Moser", "ForeName": "Christian", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Swiss Federal Institute of Intellectual Property, Stauffacherstrasse 65, CH-3003 Bern, Switzerland."}], "LastName": "Villa", "ForeName": "Anna M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Swiss Federal Institute of Intellectual Property, Stauffacherstrasse 65, CH-3003 Bern, Switzerland."}], "LastName": "Mueller", "ForeName": "Heinz", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Pat Anal", "NlmUniqueID": "101582615", "ISSNLinking": "2046-8954"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Drug Industry"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "International Cooperation"}, {"QualifierName": [], "DescriptorName": "Patents as Topic"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "10", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31612798", "10.4155/ppa-2019-0017"]}}]}